Outcomes of patients with oesophageal cancer treated with preoperative chemoradiotherapy, followed by tumor resection: Influence of nutritional factors

Journal of B.U.ON.

Volumn 17, Issue 2, 2012, Pages 310-316

  Zemanova, Milada ^a   Novak, F ^a   Vitek P ^b   Pazdro, A ^c   Smejkal, M ^c   Pazdrova, G ^a   Petruzelka, L ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Neoadjuvant chemoradiotherapy; Nutritional support; Oesophageal cancer; Serum albumin; Weight loss

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL; SERUM ALBUMIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ANEMIA; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CONTINUOUS INFUSION; DYSPHAGIA; ESOPHAGUS CANCER; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NOSE FEEDING; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TASK PERFORMANCE; THROMBOCYTOPENIA; WEIGHT CHANGE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DEGLUTITION DISORDERS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NUTRITIONAL STATUS; PREOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84863625330     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-234. (Pubitemid 46291702)
2. Fiorica F, DiBona D, Schepis F et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004; 53: 925-930. (Pubitemid 38824146)
3. Hennequin C, Gayet B, Sauvanet A et al. Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus. Int J Radiat Oncol Biol Phys 2001;49:657-664. (Pubitemid 32112193)
4. Andreyev HJN, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998; 34: 503-509. (Pubitemid 28179346)
5. TNM Classification of Malignant Tumors (5 th Edn). UICC - International Union Against Cancer. Sobin LH, Wittektad C (Eds), Wiley-Liss, 1997, Czech version, Prague 2000.
6. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
7. Cox DR. Regression Models and Life Tables. J R Stat Soc 1972; B 34: 187-220.
8. Zemanova M, Petruzelka L, Pazdro A et al. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up. Dis Esophagus 2010; 23: 160-167.
9. Di Fiore F, Lacleire S, Pop D et al. Baseline nutritional status is predictive of response to treatment and survival in patient treated by definitive chemoradiotherapy for locally advanced esophageal cancer. Am J Gastroenterol 2007; 102: 2557-2563. (Pubitemid 47631770)
10. Jeremic B, Shibamoto Y. Pre-treatment prognostic factors in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy. Lung Cancer 1995; 13: 121-130.
11. O'Brien M, Bonomi P, Langer C et al. Analysis of prognostic factors in chemo-naive patients with advanced NSCLC and poor performance status (PS): Cox regression analysis of two phase III trials. J Clin Oncol 2006; 24: 7117 (abstr).
12. Stanisavljevic NS, Marisavljevic DZ. Weight and body composition changes during R-CHOP chemotherapy in patients with non-Hodgkin's lymphoma and their impact on dose intensity and toxicity. J BUON 2010; 15: 290-296.
13. Meta-analysis Group in Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 1998; 16: 301-308.
14. Yeun JY, Kaysen GA. Factors influencing serum albumin in dialysis patients. Am J Kidney Dis 1998; 32(6 Suppl 4): S118-125.
15. Oñate-Ocańa LF, Cortés-Cárdenas SA, Aiello-Crocifoglio V, Mondragón-Sánchez R, Ruiz-Molina JM. Preoperative multivariate prediction of morbidity after gastrectomy for adenocarcinoma. Ann Surg Oncol 2000; 7: 281-288. (Pubitemid 30318316)
16. Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutr J 2010; 9: 69.